Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Oral Vaccines Sometimes Fail in Resource-Poor Countries – New Research Helps Explain Why
    Health

    Oral Vaccines Sometimes Fail in Resource-Poor Countries – New Research Helps Explain Why

    By University of PittsburghAugust 3, 2021No Comments5 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Healthy Mouse Intestine vs Environmental Enteric Dysfunction
    Healthy mouse intestine with long, finger-like villi (left) and intestine of mouse with environmental enteric dysfunction with shortened villi (right). Credit: Amrita Bhattacharjee

    Poor sanitation-linked gut disorder disrupts oral vaccine immunity, but targeting gut bacteria may restore vaccine effectiveness.

    A chronic gut disorder that occurs in regions with poor sanitation disrupts intestinal immune responses and impairs oral vaccine effectiveness in a mouse model of the disease, according to research led by UPMC Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine scientists.

    The finding, published today (August 3, 2021) in Immunity, is important because oral vaccines delivered by liquid drops to the mouth, such as polio and rotavirus vaccines, are especially useful in low-income countries that may not have health care workers trained in administering vaccines through needles. They may also stimulate better local immunity in the gut, which is key for fending off diseases contracted by contaminated food and water­ ­­— including some of the very infections that contribute to the gut disorder, called environmental enteric dysfunction, or EED.

    “It is tragic that the exact vaccines that might help prevent EED don’t work in children who have the disease,” said Timothy Hand, Ph.D., senior author of the study and assistant professor of pediatrics and immunology at the R.K. Mellon Institute for Pediatric Research at UPMC Children’s and director of Pitt’s Gnotobiotic Core.

    EED is caused by malnutrition and chronic gastrointestinal infection from contaminated food and water. Infection with viruses, parasites or bacteria combined with poor diet can trigger gut inflammation and damage the finger-like projections called villi that help absorb nutrients from food.

    “EED can affect anyone, but it’s a major problem in children because they’re still developing,” said Hand. “The result is that children with EED are stunted. They end up shorter in stature. But perhaps more importantly, it can significantly affect brain development: These children have less cognitive ability. And this is a lifelong problem; you can’t restore that development later in life.”

    To learn more about the mechanisms behind oral vaccine failure, Hand and his team developed a mouse model of the disease. They induced EED-like symptoms by feeding the rodents a diet deficient in fat and protein and inoculating them with a strain of E. coli bacteria that invades gut cells.

    Like humans with the disease, EED mice had stunted growth, shifts in the gut microbiome composition, elevated gut inflammation and shortened gut villi compared with control mice that received a normal diet with adequate fat and protein or animals that received a normal diet and bacteria or a poor diet without bacteria.

    After giving the mice an oral vaccine, the researchers found that immune responses were severely compromised in those with EED. Vaccine-specific CD4+ T cells in the small intestine were about 18 times lower than in control mice.

    Gut Microbiome and Inflammation Drive Vaccine Failure

    Further experiments indicated that oral vaccine failure in EED mice was mediated by their gut microbiome. In response to microbiome-associated inflammation, T regulatory (Treg) cells accumulate in the small intestine of EED mice.

    “Treg cells arise because there’s too much inflammation and they help tamp down that inflammation,” said Hand. “But unfortunately, a side effect is that they prevent local accumulation of vaccine-specific CD4+ T cells.”

    When the team used antibiotics to eliminate gut bacteria, vaccine effectiveness was restored in EED mice.

    According to Hand, these findings support the idea that targeting the microbiome could help treat EED and improve vaccine success in children.

    “Judicious use of antibiotics in these children might be able to reset the small intestinal microbiome, reduce inflammation in the small intestine and reduce those Tregs,” he said.

    EED is rare in resource-rich countries but common in poorer countries that lack sewage systems and sanitation. About 150 million children worldwide live in conditions that put them at risk of getting the disease.

    Prevention Hinges on Global Sanitation

    “If we could get flush toilets and plumbing to the world, we wouldn’t have this disease,” said Hand. “What’s causing these chronic infections is that people are either drinking contaminated water or flies are transporting diseases from sewage to food.”

    In the future, Hand and his team plan to collaborate with researchers in countries where EED is a problem to better understand vaccine outcomes in children with this disease.

    Reference: “Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+ T cell responses and impair oral vaccine efficacy” by Amrita Bhattacharjee, Ansen H.P. Burr, Abigail E. Overacre-Delgoffe, Justin T. Tometich, Deyi Yang, Brydie R. Huckestein, Jonathan L. Linehan, Sean P. Spencer, Jason A. Hall, Oliver J. Harrison, Denise Morais da Fonseca, Elizabeth B. Norton, Yasmine Belkaid and Timothy W. Hand, 3 August 2021, Immunity.
    DOI: 10.1016/j.immuni.2021.07.005

    Additional authors on the research are Amrita Bhattacharjee, Ph.D., Ansen H.P. Burr, Abigail E. Overacre-Delgoffe, Ph.D., Justin T. Tometich and Brydie R. Huckestein, all of Pitt or UPMC, or both; Deyi Yang, of UPMC and Central South University, China; Jonathan L. Linehan, Ph.D., Sean P. Spencer, M.D., Ph.D., Jason A. Hall, Ph.D., Oliver J. Harrison, Ph.D., Denise Morais da Fonseca, Ph.D., and Yasmine Belkaid, PhD., all of the National Institutes of Health; and Elizabeth B. Norton, Ph.D., of Tulane University.

    This research was supported by National Institutes of Health awards R21AI142051, 2015/25364-0 and T32AI089443, the R.K. Mellon Institute for Pediatric Research and UPMC Children’s Hospital of Pittsburgh.

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Gastroenterology Immunology Infectious Diseases University of Pittsburgh Vaccine
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    What Actually Happens When COVID-19 Vaccines Enter the Body?

    Critical Insight Into COVID-19 Immune Response From New Study of Serum Samples

    Long-Lived Antibodies Detected in Both Blood and Saliva of Patients With COVID-19

    SARS-CoV-2 Antibodies Provide Lasting COVID-19 Immunity

    Ab8 COVID-19 Drug Breakthrough: Tiny Antibody Component Completely Neutralizes the SARS-CoV-2 Virus

    New Insight on How to Build a Better Flu Vaccine – For Long-Lasting Immunity Against New Influenza Strains

    Generic BCG Vaccine Could Be Effective Against COVID-19

    Research Shows Exposure to Common Cold Coronaviruses Can Teach the Immune System to Recognize SARS-CoV-2

    Common Molecular Feature of Antibodies That Neutralize SARS-CoV-2 Discovered, Boosting COVID-19 Vaccine Prospects

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Collapsing Plasma May Hold the Key to Cosmic Magnetism

    This Breakthrough Solar Panel Generates Power From Both Sunlight and Raindrops

    Scientists Uncover New Metabolic Effects Beyond Weight Loss of Mounjaro

    Scientists Discover Cancer Tumors Are “Addicted” to This Common Antioxidant

    1,800 Miles Down: Scientists Uncover Mysterious Movements at the Edge of Earth’s Core

    Scientists Discover Hidden “Good Fats” in Green Rice That Could Transform Nutrition

    Your Child’s Clothes Could Contain Toxic Lead, Study Finds

    Researchers Break a 150-Year-Old Math Law With a Surprising Donut Discovery

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Natural Oils vs. Antibiotics: The Swine Study That Could Change Farming
    • The Biggest Volcanic Event in Earth’s History Transformed an Entire Oceanic Plate
    • Scientists Warn: Humanity Has Pushed the Planet Past Its Limits
    • Stronger Flu Shot Linked to Nearly 55% Lower Alzheimer’s Risk, Study Finds
    • Researchers Say That Eating Mango With Avocado Offers Surprising Heart Benefits
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.